IDL Diagnostics AB (OSTO:IDLDX) Tariff Resilience Score: 0/10 (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:IDLDX IDL Diagnostics AB OSTO:IDLDX
55 GF Score
Price kr0.42
GF Value kr0.54
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is IDL Diagnostics AB Tariff Resilience Score?

IDL Diagnostics AB has the Tariff Resilience Score of 0, which implies that the company might have .

IDL Diagnostics AB has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes IDL Diagnostics AB might have .

IDL Diagnostics AB  (OSTO:IDLDX) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

IDL Diagnostics AB Tariff Resilience Score Related Terms

OSTO:IDLDX
55GF Score
IDL Diagnostics AB OSTO:IDLDX
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is IDL Diagnostics AB (OSTO:IDLDX) Overvalued in 2026?

Based on GuruFocus' analysis, IDL Diagnostics AB stock appears to be undervalued. The current stock price of kr0.42 is trading 21.9% below its estimated GF Value™ of kr0.54. GuruFocus considers IDL Diagnostics AB to be Modestly Undervalued.

Key valuation signals for OSTO:IDLDX:

  • Tariff Resilience Score: 0
  • GF Value™: kr0.54 vs. price of kr0.42 (21.9% below fair value)
  • GF Score™: 55/100 with 2 warning signs

No single metric tells the full story. See the OSTO:IDLDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IDL Diagnostics AB Business Description

Address Karlsbodavagen 39, Bromma, Stockholm, SWE, 168 67
IDL Diagnostics AB is a Swedish company that develops and markets blood and urine sample tests. It specializes in oncology and bacteriology. The company has a broad product portfolio, is used in healthcare, and is established in various markets. In oncology, IDL Diagnostics uses various biomarkers, TK1 and cytokeratins, to support the treatment of cancers such as breast, prostate, and bladder cancers.
55GF Score

Get the complete analysis for OSTO:IDLDX

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.42
Price
kr0.54
GF Value